Child Anthropometrics and Neurodevelopment at 2 and 3 Years of Age Following an Antenatal Lifestyle Intervention in Routine Care-A Secondary Analysis from the Cluster-Randomised GeliS Trial.
Monika SpiesKristina GeyerRoxana RaabStephanie BrandtDorothy Marie MeyerJulia GüntherJulia HoffmannHans HaunerPublished in: Journal of clinical medicine (2022)
Maternal characteristics around pregnancy may influence obesity risk and neurodevelopment in children. To date, the effect of antenatal lifestyle interventions on long-term child development is unclear. The objective was to investigate the potential long-term effects of an antenatal lifestyle intervention programme conducted alongside routine care on child anthropometrics and neurodevelopment up to 3 years of age. Mother-child pairs from the cluster-randomised GeliS trial were followed up to 3 years of age. Data on child anthropometrics in both groups were collected from routine health examinations. Neurodevelopment was assessed via questionnaire. Of the 2286 study participants, 1644 mother-child pairs were included in the analysis. Children from the intervention group were less likely to score below the cut-off in Fine motor ( p = 0.002), and more likely to have a score below the cut-off in Problem-solving ( p < 0.001) compared to the control group at 3 years of age. Mean weight, height, head circumference, body mass index, and the respective z-scores and percentiles were comparable between the groups at 2 and 3 years of age. We found no evidence that the lifestyle intervention affected offspring development up to 3 years of age. Further innovative intervention approaches are required to improve child health in the long-term.
Keyphrases
- randomized controlled trial
- mental health
- weight loss
- metabolic syndrome
- study protocol
- physical activity
- clinical trial
- healthcare
- pregnant women
- body mass index
- preterm birth
- cardiovascular disease
- public health
- young adults
- palliative care
- open label
- type diabetes
- clinical practice
- quality improvement
- risk assessment
- phase iii
- air pollution
- high fat diet
- placebo controlled
- health information
- climate change
- artificial intelligence
- data analysis